TrialX provides cutting-edge information on new medical treatments and clinical trials in your area.
Meet Dory , your personalized virtual assistant to find clinical trials. Go head, ask her anything. x
All > Massachusetts Investigators

Mark Huberman, MD

Beth Israel Deaconess Medical Center

Boston, Massachusetts - 02215

Beth Isreal Deaconess Medical Center

Boston, Massachusetts - 02215 (617-632-9280)
  • SINCE2008
Study of Hsp90 Inhibitor STA-9090 for Relapsed or Refractory Small Cell Lung Cancer

July 2010 - August 2012
A Study of the HSP90 Inhibitor STA-9090 in Subjects With Stage IIIB or IV Non-Small Cell Lung Cancer (NSCLC)

November 2009 - September 2011
An Efficacy Study of MORAb-009 Amatuximab in Subjects With Pleural Mesothelioma

December 2008 - March 2012
Lung Neoplasms

Carcinoma, Non-Small-Cell Lung


Carcinoma, Small Cell


Sta 9090

Morab-009 Amatuximab By Iv On Days 1 And 8 Every 21 Days For 6 Cycles.

©2013 Applied Informatics, Inc.
As Seen On:
  • New York Times
  • USA Today
  • bio-itworld logo